— Know what they know.
Not Investment Advice
Also trades as: 0EE0.L (LSE) · $vol 0M

QURE NASDAQ

uniQure N.V.
1W: -38.6% 1M: -49.2% 3M: -43.3% YTD: +0.3% 1Y: -57.3% 3Y: +240.0% 5Y: -30.5%
$23.46
+0.09 (+0.39%)
 
Weekly Expected Move ±19.6%
$14 $19 $23 $28 $33
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 29 · $1.6B mcap · 62M float · 3.45% daily turnover · Short 30% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
42.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 37.9%
Cost Advantage
38
Intangibles
26
Switching Cost
68
Network Effect
47
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. QURE shows a Weak competitive edge (42.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 37.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$31
Low
$54
Avg Target
$75
High
Based on 4 analysts since Jul 29, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 32Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$53.50
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-02 RBC Capital Luca Issi $65 $48 -17 +105.4% $23.37
2026-09-29 Goldman Sachs — $46 $31 -15 +26.5% $24.51
2026-09-29 Wells Fargo — $60 $75 +15 +206.0% $24.51
2026-07-30 Barclays — $65 $60 -5 +49.7% $40.07
2026-06-29 H.C. Wainwright — $50 $80 +30 +68.4% $47.51
2026-06-25 Mizuho Securities Uy Ear $33 $68 +35 +39.2% $48.85
2026-06-18 RBC Capital — $35 $65 +30 +35.0% $48.16
2026-06-18 Barclays — $31 $65 +34 +35.0% $48.16
2026-06-18 Leerink Partners Joseph Schwartz $35 $70 +35 +45.3% $48.16
2026-06-18 Goldman Sachs Salveen Richter $10 $46 +36 -4.5% $48.16
2026-06-17 Cantor Fitzgerald — $47 $61 +14 +28.7% $47.40
2026-05-06 H.C. Wainwright Patrick Trucchio $70 $50 -20 +131.1% $21.64
2026-05-05 Stifel Nicolaus Paul Matteis $14 $28 +14 +34.7% $20.78
2026-04-30 Chardan Capital — $31 $37 +6 +85.5% $19.95
2026-04-20 Goldman Sachs — $38 $10 -28 -43.1% $17.58
2026-03-09 Chardan Capital Daniil Gataulin $53 $31 -22 +72.3% $17.99
2026-03-09 Wells Fargo Yanan Zhu $80 $60 -20 +239.3% $17.68
2026-03-09 RBC Capital Luca Issi $11 $35 +24 +94.6% $17.99
2026-03-02 Leerink Partners Joseph Schwartz Initiated $35 — +233.3% $10.50
2026-03-02 RBC Capital Luca Issi $45 $11 -34 +7.3% $10.25
2026-03-02 Stifel Nicolaus Paul Matteis $40 $14 -26 +35.9% $10.30
2026-01-27 Barclays — Initiated $31 — +27.2% $24.37
2025-12-11 Stifel Nicolaus — Initiated $40 — +98.8% $20.12
2025-12-08 Mizuho Securities Uy Ear $60 $33 -27 +51.6% $21.77
2025-11-04 H.C. Wainwright Patrick Trucchio $110 $70 -40 +104.1% $34.29
2025-11-04 Goldman Sachs — $57 $38 -19 +10.8% $34.29
2025-11-03 Chardan Capital Daniil Gataulin $35 $53 +18 +55.1% $34.18
2025-11-03 RBC Capital — $24 $45 +21 +31.7% $34.18
2025-10-06 H.C. Wainwright — Initiated $110 — +100.3% $54.92
2025-10-02 Wells Fargo — $30 $80 +50 +45.5% $54.99
2025-09-25 UBS — Initiated $95 — +80.4% $52.65
2025-09-25 Mizuho Securities Uy Ear Initiated $60 — +24.8% $48.09
2025-07-30 Cantor Fitzgerald — Initiated $47 — +225.0% $14.46
2025-07-29 Chardan Capital — $60 $35 -25 +155.8% $13.68
2025-02-28 Wells Fargo — $34 $30 -4 +128.1% $13.15
2025-01-07 RBC Capital Luca Issi Initiated $24 — +36.1% $17.64
2022-11-23 Goldman Sachs — Initiated $57 — +124.6% $25.38
2022-08-08 Chardan Capital Matthew Barcus Initiated $60 — +221.9% $18.64
2022-05-03 Credit Suisse — Initiated $51 — +221.8% $15.85
2022-01-06 Wells Fargo Yanan Zhu Initiated $34 — +74.4% $19.50
2021-12-15 Raymond James Danielle Brill Initiated $58 — +186.6% $20.24
2021-10-27 Jefferies Suji Jeong Initiated $62 — +102.3% $30.65

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. QURE receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C- D+
2026-07-29 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
0
Balance Sheet
55
Earnings Quality
34
Growth
52
Value
28
Momentum
50
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. QURE scores highest in Balance Sheet (55/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.97
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-4.09
Unlikely Manipulator
Ohlson O-Score
-5.39
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
BB-
Score: 38.2/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.64x
Accruals: -11.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. QURE scores 0.97, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. QURE scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. QURE's score of -4.09 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. QURE's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. QURE receives an estimated rating of BB- (score: 38.2/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-5.81x
PEG
0.55x
P/S
87.15x
P/B
4.80x
P/FCF
-18.95x
P/OCF
—
EV/EBITDA
-12.72x
EV/Revenue
123.38x
EV/EBIT
-11.78x
EV/FCF
-14.31x
Earnings Yield
-8.27%
FCF Yield
-5.28%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. QURE currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.029
NI / EBT
×
Interest Burden
1.254
EBT / EBIT
×
EBIT Margin
-10.472
EBIT / Rev
×
Asset Turnover
0.024
Rev / Assets
×
Equity Multiplier
4.906
Assets / Equity
=
ROE
-157.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. QURE's ROE of -157.6% is driven by financial leverage (equity multiplier: 4.91x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.03 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$23.46
Median 1Y
$11.98
5th Pctile
$2.37
95th Pctile
$62.41
Ann. Volatility
105.3%
Analyst Target
$53.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Matthew Kapusta
Chief Executive Officer
$676,170 $1,079,100 $3,287,434
Christian Klemt Financial
ancial Officer
$539,220 $795,700 $2,407,410
Walid Abi-Saab Medical
edical Officer
$583,798 $414,200 $1,805,638
Jeannette Potts Legal
Legal and Compliance Officer
$495,012 $381,500 $1,499,927

CEO Pay Ratio

14:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,287,434
Avg Employee Cost (SGA/emp): $229,398
Employees: 221

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
221
+5.7% YoY
Revenue / Employee
$72,842
Rev: $16,098,000
Profit / Employee
$-900,321
NI: $-198,971,000
SGA / Employee
$229,398
Avg labor cost proxy
R&D / Employee
$608,262
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 78.3% 78.5% 83.8% -20.4% -24.8% -23.7% -32.8% -44.5% -66.2% -90.2% -1.1% -1.3% -1.5% -2.4% -2.4% -4.3% -1.7% -2.1% -2.3% -1.6% -1.58%
ROA 57.0% 57.3% 57.9% -15.4% -17.7% -16.7% -22.7% -22.7% -30.3% -40.1% -42.4% -34.0% -31.6% -34.5% -31.6% -30.2% -30.7% -28.8% -30.2% -32.1% -32.13%
ROIC 2.4% 1.8% 1.9% -96.7% -1.1% -42.5% -53.9% -57.6% -1.2% 82.2% -1.6% -1.8% -1.3% 47.2% 43.3% 42.5% 35.6% -1.3% 40.4% 37.9% 37.94%
ROCE 41.8% 41.8% 44.2% -19.3% -21.8% -17.2% -23.2% -17.8% -23.0% -35.0% -33.8% -33.3% -29.6% -33.6% -26.8% -24.8% -20.6% -17.2% -19.8% -21.7% -21.68%
Gross Margin -17.1% 34.4% -22.9% -67.4% 40.6% 98.4% 54.3% 44.2% 28.5% -32.1% -8.7% 32.9% 55.4% 88.1% 87.4% 87.5% 89.2% 38.8% 93.9% -78.0% -77.97%
Operating Margin -22.6% 3.6% -30.2% -112.8% -41.1% 25.8% -13.9% -26.9% -58.2% -9.2% -6.4% -4.0% -17.6% -8.8% -25.1% -8.3% -13.8% -9.4% -12.4% -9.6% -9.57%
Net Margin -18.4% 14.2% -26.0% -78.6% -33.0% 6.6% -14.5% -28.3% -63.7% -10.9% -7.7% -5.1% -19.4% -14.0% -27.8% -7.2% -21.8% -6.7% -15.0% -13.9% -13.88%
EBITDA Margin -22.2% 17.7% -27.8% -69.8% -29.7% 27.4% -13.6% -24.3% -50.9% -7.5% -5.4% -3.3% -10.8% -10.2% -15.0% -3.4% -13.9% -4.2% -10.1% -12.0% -11.98%
FCF Margin 56.2% 51.6% 54.4% -2.4% -2.5% -1.5% -1.9% -2.2% -1.4% -9.7% -7.1% -4.0% -6.8% -7.2% -8.7% -12.7% -9.8% -11.1% -9.5% -8.6% -8.62%
OCF Margin 59.5% 55.0% 57.8% -2.1% -2.2% -1.4% -1.8% -2.1% -1.4% -9.2% -6.7% -3.8% -6.3% -6.7% -8.2% -12.1% -9.7% -11.1% -9.5% -8.6% -8.61%
ROA 3Y Avg snapshot only -32.86%
ROIC Economic snapshot only -41.56%
Cash ROA snapshot only -16.32%
NOPAT Margin snapshot only -8.60%
Pretax Margin snapshot only -13.13%
R&D / Revenue snapshot only 7.03%
SGA / Revenue snapshot only 4.04%
SBC / Revenue snapshot only 97.96%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 4.61 2.95 2.60 -7.63 -7.00 -8.40 -6.07 -2.92 -1.40 -1.05 -0.85 -0.77 -1.00 -3.60 -2.59 -3.84 -14.53 -6.92 -4.91 -12.10 -5.807
P/S Ratio 2.95 1.85 1.60 14.04 14.28 10.00 8.68 4.88 2.86 20.44 13.24 7.86 8.40 31.81 27.87 53.29 216.85 85.48 56.70 163.41 87.154
P/B Ratio 2.50 1.63 1.54 1.79 2.08 2.24 2.31 1.55 1.19 1.56 1.71 2.24 4.30 -127.74 16.71 -190.86 14.93 6.92 6.87 9.42 4.796
P/FCF 5.25 3.59 2.95 -5.86 -5.71 -6.54 -4.47 -2.17 -1.99 -2.12 -1.86 -1.97 -1.24 -4.44 -3.20 -4.18 -22.23 -7.73 -5.96 -18.95 -18.950
P/OCF 4.96 3.37 2.77 — — — — — — — — — — — — — — — — — —
EV/EBITDA 3.21 1.67 1.40 -4.30 -4.91 -8.60 -6.41 -2.94 -1.05 0.61 -1.05 -1.11 -1.94 -3.49 -1.60 -3.80 -19.05 -11.07 -3.89 -12.72 -12.723
EV/Revenue 2.01 1.05 0.86 8.21 9.37 8.03 7.11 3.83 1.64 -9.82 12.55 8.22 10.70 20.69 10.90 31.65 176.97 80.14 27.78 123.38 123.377
EV/EBIT 3.29 1.71 1.44 -4.03 -4.59 -7.92 -5.97 -2.76 -0.99 0.59 -1.00 -1.05 -1.80 -3.24 -1.44 -3.36 -17.16 -9.82 -3.53 -11.78 -11.782
EV/FCF 3.58 2.04 1.58 -3.42 -3.75 -5.25 -3.66 -1.71 -1.14 1.02 -1.76 -2.06 -1.58 -2.89 -1.25 -2.49 -18.15 -7.25 -2.92 -14.31 -14.307
Earnings Yield 21.7% 33.9% 38.5% -13.1% -14.3% -11.9% -16.5% -34.2% -71.3% -95.3% -1.2% -1.3% -99.7% -27.8% -38.6% -26.0% -6.9% -14.5% -20.4% -8.3% -8.27%
FCF Yield 19.0% 27.8% 34.0% -17.1% -17.5% -15.3% -22.4% -46.0% -50.3% -47.3% -53.8% -50.8% -80.4% -22.5% -31.2% -23.9% -4.5% -12.9% -16.8% -5.3% -5.28%
PEG Ratio snapshot only 0.549
Price/Tangible Book snapshot only 12.855
EV/Gross Profit snapshot only 541.408
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 14.17 17.09 12.94 10.84 7.26 6.28 6.67 11.07 10.11 8.85 9.39 7.36 6.51 9.74 11.99 9.98 7.12 10.43 10.40 10.01 10.010
Quick Ratio 14.17 17.09 12.94 10.78 7.20 6.19 6.56 10.92 9.88 8.68 9.27 7.36 6.51 9.74 11.99 9.98 7.12 10.43 10.40 10.01 10.010
Debt/Equity 0.18 0.23 0.25 0.29 0.33 0.30 0.34 1.45 1.94 0.67 3.70 5.50 8.98 -9.78 1.97 -16.66 0.29 2.70 0.42 0.19 0.194
Net Debt/Equity -0.80 -0.71 -0.71 -0.74 -0.72 -0.44 -0.42 -0.33 -0.51 -2.31 -0.09 0.10 1.18 — -10.18 — -2.75 -0.43 -3.50 -2.31 -2.307
Debt/Assets 0.14 0.17 0.18 0.20 0.22 0.20 0.23 0.54 0.60 0.17 0.70 0.73 0.78 0.12 0.11 0.11 0.07 0.65 0.08 0.06 0.064
Debt/EBITDA 0.34 0.41 0.42 -1.18 -1.18 -1.44 -1.16 -3.50 -2.99 -0.55 -2.39 -2.61 -3.17 -0.41 -0.48 -0.56 -0.45 -4.60 -0.49 -0.35 -0.347
Net Debt/EBITDA -1.50 -1.27 -1.21 3.05 2.57 2.11 1.42 0.80 0.78 1.89 0.06 -0.05 -0.42 1.88 2.48 2.60 4.29 0.74 4.05 4.13 4.128
Interest Coverage 48.46 43.17 37.36 -13.66 -12.08 -9.22 -10.27 -9.21 -6.31 -6.38 -4.42 -3.42 -2.64 -2.72 -2.43 -2.17 -2.61 -2.12 -2.34 -3.28 -3.276
Equity Multiplier 1.31 1.36 1.39 1.44 1.52 1.48 1.53 2.67 3.24 4.00 5.25 7.53 11.57 -82.43 17.97 -146.11 3.88 4.15 5.21 3.04 3.040
Cash Ratio snapshot only 9.723
Debt Service Coverage snapshot only -3.033
Cash to Debt snapshot only 12.896
FCF to Debt snapshot only -2.563
Defensive Interval snapshot only 1434.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.89 0.91 0.94 0.08 0.09 0.14 0.16 0.14 0.15 0.02 0.03 0.03 0.04 0.04 0.03 0.02 0.02 0.02 0.03 0.02 0.024
Inventory Turnover — — — 79.70 40.42 13.33 1.55 0.96 0.65 1.44 2.70 5.20 3.39 3.05 2.42 — — — — — —
Receivables Turnover 250.57 16.03 23.83 21.28 16.66 1.32 1.53 2.12 42.65 0.30 0.33 0.50 8.21 5.38 3.05 2.13 3.42 1.71 5.95 3.28 3.280
Payables Turnover 32.00 41.35 17.85 8.76 12.73 6.84 0.61 0.65 0.98 1.55 2.89 3.85 4.82 2.65 1.77 0.50 0.32 0.75 0.97 2.74 2.741
DSO 1 23 15 17 22 276 238 172 9 1228 1109 727 44 68 120 171 107 213 61 111 111.3 days
DIO 0 0 0 5 9 27 236 381 559 254 135 70 108 120 151 0 0 0 0 0 0.0 days
DPO 11 9 20 42 29 53 594 562 372 235 126 95 76 138 206 728 1139 486 377 133 133.2 days
Cash Conversion Cycle -10 14 -5 -20 2 250 -120 -9 195 1246 1119 703 76 50 64 -557 -1032 -273 -316 -22 -21.9 days
Fixed Asset Turnover snapshot only 0.812
Cash Velocity snapshot only 0.023
Capital Intensity snapshot only 52.758
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 81.7% 13.0% 12.9% -87.6% -87.7% -79.7% -79.1% 80.6% 82.2% -85.1% -82.7% -75.2% -74.5% 71.2% 6.3% -48.3% -44.9% -40.6% -10.4% 30.2% 30.24%
Net Income 2.9% 3.6% 3.3% -1.4% -1.4% -1.4% -1.5% -63.7% -82.2% -1.4% -88.7% -52.4% -4.8% 22.3% 26.7% 30.1% 1.8% 16.9% 4.0% -26.7% -26.74%
EPS 2.9% 3.5% 3.3% -1.4% -1.4% -1.4% -1.5% -60.4% -78.4% -1.4% -85.0% -49.4% -2.8% 23.9% 33.2% 38.0% 18.3% 29.5% 18.7% -4.9% -4.86%
FCF 3.1% 2.9% 2.9% -1.5% -1.5% -1.6% -1.7% -69.3% -4.9% 5.9% 36.6% 56.0% -19.7% -27.0% -29.8% -65.1% 20.4% 8.5% 2.1% 11.8% 11.80%
EBITDA 3.2% 3.8% 3.4% -1.4% -1.4% -1.3% -1.4% -23.5% -49.0% -1.5% -86.1% -40.0% 9.7% 36.5% 39.2% 41.6% 7.3% 27.5% 6.4% -51.4% -51.43%
Op. Income 3.0% 3.5% 3.2% -1.5% -1.6% -1.5% -1.5% -12.5% -16.1% -97.6% -61.1% -40.4% -2.9% 34.8% 35.6% 30.0% 10.1% -1.1% -12.9% -20.1% -20.15%
OCF Growth snapshot only 7.29%
Asset Growth snapshot only 68.43%
Debt Growth snapshot only -5.79%
Shares Change snapshot only 20.87%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 2.4% 2.6% 2.9% 94.9% 1.1% 1.4% 1.6% 1.8% 1.6% -25.0% -20.5% -61.9% -61.5% -62.7% -66.2% -38.6% -36.5% -46.7% -45.2% -45.0% -44.95%
Revenue 5Y 90.9% 83.6% 85.4% 20.3% 25.7% 52.0% 52.7% 58.0% 55.6% 7.0% 16.3% 27.1% 35.5% 30.1% 26.4% 22.0% 21.1% -15.6% -13.7% -48.2% -48.19%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — -27.6% — -85.8% -82.4% -71.9% -69.5% — — -42.5% -49.5% -65.7% -65.72%
Gross Profit 5Y 81.1% 74.2% 1.2% — — — — — — — — — — — — — — 14.4% — -59.9% -59.94%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 40.2% 43.5% 41.2% 40.5% 10.6% 16.3% 15.1% 34.7% 35.5% 34.7% 28.4% -2.3% -5.9% -11.7% -7.2% -5.9% 11.7% 5.4% 7.3% 1.5% 1.47%
Assets 5Y 29.3% 33.6% 34.9% 34.7% 35.6% 27.5% 26.8% 25.0% 25.4% 24.9% 23.4% 23.6% 6.5% 4.4% 7.9% 8.7% 20.4% 19.4% 16.4% 4.7% 4.67%
Equity 3Y 43.5% 49.1% 51.5% 54.4% 6.3% 13.8% 11.8% 10.0% 5.7% -5.2% -13.7% -46.5% -54.5% — -60.5% — -18.4% -25.2% -28.7% -2.8% -2.84%
Book Value 3Y 33.6% 36.2% 41.1% 44.0% 1.6% 7.9% 9.3% 7.4% 3.2% -7.5% -15.5% -47.1% -55.3% — -62.2% — -24.3% -30.1% -35.1% -12.9% -12.95%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.38 0.42 0.42 0.16 0.17 0.24 0.24 0.06 0.06 0.01 0.02 0.02 0.02 0.04 0.04 0.00 0.01 0.17 0.17 0.79 0.792
Earnings Stability 0.25 0.31 0.29 0.08 0.07 0.09 0.06 0.00 0.01 0.03 0.03 0.15 0.11 0.14 0.12 0.31 0.28 0.28 0.26 0.60 0.597
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.33 0.00 0.29 0.288
Rev. Growth Consistency 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.98 0.91 0.89 0.88 0.99 0.93 0.98 0.89 0.893
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 1.06 1.00 1.11 -0.22 -0.21 -0.29 -0.38 -0.65 -0.97 -1.63 -2.13 -2.55 -3.72 — -5.26 — 1.54 — 2.84 — —
Gross Margin Trend 8.85 6.68 6.52 2.90 0.97 0.11 0.93 0.98 0.74 -0.52 -0.92 0.02 -0.23 -0.03 0.10 0.33 0.37 0.48 0.51 -0.21 -0.206
FCF Margin Trend 19.17 9.67 11.65 8.59 8.16 0.14 -0.19 -1.34 -0.47 -9.16 -6.42 -1.67 -4.78 -1.57 -4.17 -9.61 -5.66 -2.64 -1.60 -0.26 -0.260
Sustainable Growth Rate 78.3% 78.5% 83.8% — — — — — — — — — — — — — — — — — —
Internal Growth Rate 1.3% 1.3% 1.4% — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.93 0.87 0.94 1.13 1.10 1.14 1.26 1.28 0.66 0.47 0.43 0.37 0.75 0.76 0.76 0.87 0.65 0.89 0.82 0.64 0.638
FCF/OCF 0.94 0.94 0.94 1.15 1.12 1.12 1.08 1.05 1.07 1.05 1.06 1.06 1.08 1.06 1.06 1.05 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.638
CapEx/Revenue 3.3% 3.3% 3.4% 32.1% 26.3% 16.6% 14.5% 11.1% 9.1% 45.2% 37.7% 24.1% 47.8% 43.1% 46.9% 63.7% 2.4% 0.0% 0.1% 1.2% 1.21%
CapEx/Depreciation snapshot only 0.016
Accruals Ratio 0.04 0.07 0.04 0.02 0.02 0.02 0.06 0.06 -0.10 -0.21 -0.24 -0.22 -0.08 -0.08 -0.07 -0.04 -0.11 -0.03 -0.05 -0.12 -0.116
Sloan Accruals snapshot only 0.470
Cash Flow Adequacy snapshot only -711.447
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — — —
FCF Payout Ratio 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — — —
Total Payout Ratio 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -2.1% -3.0% -0.0% -0.3% -0.1% -0.2% -0.2% -0.4% -0.5% -0.1% -0.1% -0.1% -0.1% -0.2% -14.7% -11.2% -11.6% 0.0% -7.8% -5.4% -5.44%
Total Shareholder Return -2.1% -3.0% -0.0% -0.3% -0.1% -0.2% -0.2% -0.4% -0.5% -0.1% -0.1% -0.1% -0.1% -0.2% -14.7% -11.2% -11.6% 0.0% -7.8% -5.4% -5.44%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.94 0.99 0.99 1.00 0.99 0.99 0.99 0.99 0.99 1.01 1.01 1.02 1.02 1.01 1.01 1.01 1.05 1.03 1.03 1.03 1.029
Interest Burden (EBT/EBIT) 1.11 1.03 1.04 0.91 1.01 1.19 1.22 1.21 1.24 1.16 1.23 1.29 1.38 1.37 1.41 1.46 1.38 1.47 1.43 1.25 1.254
EBIT Margin 0.61 0.62 0.60 -2.04 -2.04 -1.01 -1.19 -1.39 -1.65 -16.73 -12.58 -7.82 -5.96 -6.39 -7.55 -9.42 -10.31 -8.16 -7.87 -10.47 -10.472
Asset Turnover 0.89 0.91 0.94 0.08 0.09 0.14 0.16 0.14 0.15 0.02 0.03 0.03 0.04 0.04 0.03 0.02 0.02 0.02 0.03 0.02 0.024
Equity Multiplier 1.37 1.37 1.45 1.33 1.40 1.41 1.45 1.96 2.19 2.25 2.50 3.72 4.67 6.91 7.62 14.13 5.39 7.19 7.56 4.91 4.906
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $6.95 $7.04 $6.96 $-2.44 $-2.68 $-2.70 $-3.32 $-3.92 $-4.78 $-6.45 $-6.14 $-5.86 $-4.92 $-4.90 $-4.10 $-3.63 $-4.02 $-3.46 $-3.33 $-3.81 $-3.81
Book Value/Share $12.80 $12.72 $11.72 $10.42 $9.00 $10.13 $8.70 $7.41 $5.63 $4.34 $3.03 $2.00 $1.15 $-0.14 $0.63 $-0.07 $3.91 $3.46 $2.38 $4.89 $4.89
Tangible Book/Share $10.81 $10.79 $9.83 $8.66 $7.35 $8.34 $6.89 $5.62 $3.88 $2.53 $1.28 $0.32 $-0.92 $-2.05 $-1.16 $-1.91 $2.21 $1.75 $0.87 $3.58 $3.58
Revenue/Share $10.84 $11.19 $11.27 $1.33 $1.31 $2.27 $2.32 $2.35 $2.34 $0.33 $0.39 $0.57 $0.59 $0.56 $0.38 $0.26 $0.27 $0.28 $0.29 $0.28 $0.28
FCF/Share $6.09 $5.78 $6.14 $-3.18 $-3.28 $-3.47 $-4.50 $-5.28 $-3.38 $-3.20 $-2.80 $-2.27 $-3.96 $-3.98 $-3.31 $-3.33 $-2.63 $-3.09 $-2.74 $-2.43 $-2.43
OCF/Share $6.45 $6.15 $6.51 $-2.76 $-2.94 $-3.09 $-4.17 $-5.02 $-3.16 $-3.05 $-2.65 $-2.14 $-3.68 $-3.74 $-3.13 $-3.16 $-2.62 $-3.09 $-2.74 $-2.43 $-2.43
Cash/Share $12.53 $11.88 $11.26 $10.73 $9.41 $7.51 $6.65 $13.19 $13.79 $12.92 $11.48 $10.79 $8.93 $7.52 $7.70 $6.88 $11.86 $10.83 $9.35 $12.23 $12.23
EBITDA/Share $6.80 $7.04 $6.93 $-2.54 $-2.51 $-2.12 $-2.57 $-3.07 $-3.66 $-5.29 $-4.69 $-4.21 $-3.24 $-3.29 $-2.60 $-2.18 $-2.50 $-2.03 $-2.06 $-2.73 $-2.73
Debt/Share $2.32 $2.90 $2.91 $2.98 $2.97 $3.04 $2.99 $10.74 $10.93 $2.89 $11.21 $10.99 $10.28 $1.35 $1.25 $1.22 $1.13 $9.33 $1.01 $0.95 $0.95
Net Debt/Share $-10.21 $-8.98 $-8.36 $-7.74 $-6.45 $-4.47 $-3.65 $-2.46 $-2.87 $-10.02 $-0.27 $0.21 $1.35 $-6.17 $-6.45 $-5.66 $-10.73 $-1.49 $-8.34 $-11.28 $-11.28
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.968
Altman Z-Prime snapshot only 3.670
Piotroski F-Score 6 7 7 1 1 1 1 3 3 3 2 1 2 6 6 5 5 3 4 4 4
Beneish M-Score -0.09 2.52 3.01 870.31 -25.18 -1.83 -23.29 5.29 -3.26 -9.18 -7.59 -1.03 -1.36 -2.89 -4.28 -2.89 -3.09 -1.04 -1.93 -4.09 -4.090
Ohlson O-Score snapshot only -5.386
ROIC (Greenblatt) snapshot only -25.26%
Net-Net WC snapshot only $2.61
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 96.98 96.06 96.08 41.18 41.78 48.79 42.10 27.97 27.10 29.96 24.06 22.79 23.00 20.00 26.51 20.00 41.67 24.92 31.60 38.17 38.170
Credit Grade snapshot only 13
Credit Trend snapshot only 18.170
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 33
Sector Credit Rank snapshot only 30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms